Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Salud · SciRah

Researcher profile · Semantic Scholar

A. Salud

Share profile

A. Salud — researcher profile on SciRah

h-index: 30
Works: 125
Citations: 3,659

Most-cited papers

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer d
C. Fernández-Martos, C. Pericay, J. Aparicio, A. Salud +16 more
2010Journal of Clinical Oncology361 citations Open access
Semantic Scholar
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†.
C. Fernández-Martos, X. García-Albéniz, C. Pericay, J. Maurel +11 more
2015Annals of Oncology332 citations Open access
Semantic Scholar
Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
J. Porcel, M. Vives, A. Esquerda, A. Salud +2 more
2004Chest224 citations
Semantic Scholar
Clinical features and survival of lung cancer patients with pleural effusions
J. Porcel, A. Gasol, S. Bielsa, C. Civit +2 more
2015Respirology (Carlton South. Print)213 citations
Semantic Scholar
Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab.
C. Gomez-Martin, J. Plaza, R. Pazo-Cid, A. Salud +21 more
2013Journal of Clinical Oncology184 citations
Semantic Scholar
Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.
M. Nogué, A. Salud, P. Vicente, A. Arriví +8 more
2011The Oncologist172 citations Open access
Semantic Scholar
Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
J. Porcel, Paula Hernández, M. Martinez-Alonso, S. Bielsa +1 more
2015Chest113 citations
Semantic Scholar
Prognostic significance of pleural fluid data in patients with malignant effusion.
S. Bielsa, A. Salud, Montserrat Martínez, A. Esquerda +3 more
2008European journal of internal medicine112 citations
Semantic Scholar
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer
J. Feliu, A. Salud, Pilar Escudero, Luis Lopez-Gomez +9 more
2006British Journal of Cancer110 citations Open access
Semantic Scholar
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial
J. Vidal, D. Casadevall, B. Bellosillo, C. Pericay +16 more
2021Clinical Cancer Research82 citations Open access
Semantic Scholar
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
J. Codony-Servat, M. Cuatrecasas, E. Asensio, Carla Montironi +25 more
2017British Journal of Cancer73 citations Open access
Semantic Scholar
Tumor Type Influences the Effectiveness of Pleurodesis in Malignant Effusions
S. Bielsa, Paula Hernández, F. Rodríguez-Panadero, T. Taberner +2 more
2011Lung72 citations
Semantic Scholar
Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial.
C. Fernández-Martos, Gina Brown, R. Estevan, A. Salud +16 more
2014The Oncologist67 citations Open access
Semantic Scholar
A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond.
C. Gomez-Martin, F. López-Rios, J. Aparicio, J. Barriuso +7 more
2014Cancer Letters66 citations
Semantic Scholar
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
F. Rivera, C. Romero, P. Jiménez-Fonseca, M. Izquierdo-Manuel +11 more
2019Cancer Chemotherapy and Pharmacology65 citations Open access
Semantic Scholar
Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities
M. Sorolla, Iván Hidalgo, A. Sorolla, R. Montal +3 more
2021Cancers56 citations Open access
Semantic Scholar
MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial
U. Patel, G. Brown, I. Machado, J. Santos-Corés +10 more
2017Annals of Oncology56 citations Open access
Semantic Scholar
Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
A. Díaz-Serrano, B. Angulo, C. Domínguez, R. Pazo-Cid +10 more
2018The Oncologist55 citations Open access
Semantic Scholar
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
J. Feliu, M. Safont, A. Salud, F. Losa +10 more
2010British Journal of Cancer53 citations Open access
Semantic Scholar
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial.
C. Fernández-Martos, C. Pericay, F. Losa, R. García-Carbonero +16 more
2019JAMA Oncology47 citations Open access
Semantic Scholar
Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions
M. Sorolla, A. Sorolla, E. Parisi, A. Salud +1 more
2021Cancers40 citations Open access
Semantic Scholar
Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer
J. Feliu, A. Salud, M. Safont, C. García-Girón +11 more
2015PLoS ONE40 citations Open access
Semantic Scholar
Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions
J. Porcel, A. Salud, M. Nabal, M. Vives +2 more
2006Supportive Care in Cancer39 citations
Semantic Scholar
Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer
J. Feliu, C. Castañón, A. Salud, J. Mel +9 more
2005British Journal of Cancer37 citations Open access
Semantic Scholar
Predictors of Indwelling Pleural Catheter Removal and Infection
J. Porcel, M. Torres, M. Pardina, C. Civit +2 more
2019Journal of Bronchology & Interventional Pulmonology34 citations
Semantic Scholar
Clinical guideline SEOM: hepatocellular carcinoma
J. Sastre, R. Diaz-Beveridge, J. García-Foncillas, R. Guardeño +6 more
2015Clinical and Translational Oncology33 citations Open access
Semantic Scholar
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.
J. Sastre, V. de la Orden, Antonio Martínez, Inmaculada Bando +16 more
2020Clinical colorectal cancer31 citations
Semantic Scholar
First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
J. Feliú, A. Salud, M. J. Safont, C. García-Girón +12 more
2014British Journal of Cancer31 citations Open access
Semantic Scholar
MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.
U. Patel, G. Brown, I. Machado, J. Santos-Corés +10 more
2017Annals of Oncology29 citations Open access
Semantic Scholar
Breakthrough cancer pain: review and calls to action to improve its management
C. C. Herrero, N. Batista, N. Fernández, Y. E. Álvarez +5 more
2020Clinical and Translational Oncology27 citations
Semantic Scholar
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.
C. Santos, D. Azuara, J. Viéitez, D. Páez +13 more
2019Annals of Oncology27 citations Open access
Semantic Scholar
Utility of CEA and CA 15-3 measurements in non-purulent pleural exudates in the diagnosis of malignancy: A single-center experience.
J. Porcel, C. Civit, A. Esquerda, A. Salud +1 more
2017Archivos de Bronconeumologia27 citations
Semantic Scholar
[Accuracy of pleural fluid cytology in malignant effusions].
S. Bielsa, M. Panadés, R. Egido, M. Rué +4 more
2008Anales de Medicina Interna26 citations Open access
Semantic Scholar
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor Therapy.
J. Maurel, V. Alonso, P. Escudero, C. Fernández-Martos +25 more
2019JCO Precision Oncology23 citations
Semantic Scholar
A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer
F. Loupakis, A. Stein, M. Ychou, F. Hermann +2 more
2015Targeted oncology22 citations Open access
Semantic Scholar
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)
J. Fernández-Plana, C. Pericay, G. Quintero, V. Alonso +5 more
2014BMC Cancer22 citations Open access
Semantic Scholar
Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer
J. Roca, V. Alonso, C. Pericay, P. Escudero +16 more
2010Chemotherapy22 citations
Semantic Scholar
Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion
J. Porcel, C. Solé, A. Salud, S. Bielsa
2017Lung21 citations
Semantic Scholar
Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?
M. Marqués, M. Sorolla, I. Urdanibia, E. Parisi +4 more
2022Cancers19 citations Open access
Semantic Scholar
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.
A. Irigoyen, J. Gallego, Carmen Guillén Ponce, R. Vera +22 more
2017European Journal of Cancer17 citations
Semantic Scholar
Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers
J. Porcel, A. Esquerda, M. Martinez-Alonso, S. Bielsa +1 more
2016Medicine15 citations Open access
Semantic Scholar
High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.
S. Bielsa, A. Esquerda, A. Salud, A. Montes +3 more
2009European journal of internal medicine15 citations
Semantic Scholar
TTF‐1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions
J. Porcel, R. Palma, S. Bielsa, A. Esquerda +3 more
2015Respirology (Carlton South. Print)14 citations Open access
Semantic Scholar
Final analysis of irinotecan (CPT-11) and capecitabine (X) as first-line treatment of locally advanced (LA) or metastatic colorectal cancer (MCRC).
A. Muñoz, A. Salud, V. Alonso, Pilar Escudero +6 more
2004Journal of Clinical Oncology14 citations
Semantic Scholar
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study
P. García-Alfonso, M. Chaves, A. Muñoz, A. Salud +10 more
2015BMC Cancer13 citations Open access
Semantic Scholar
Three-year outcomes of GCR-3: A phase II randomized trial comparing conventional preoperative chemoradiation (CRT) followed by surgery and postoperative adjuvant chemotherapy (CT) with induction CT followed by CRT and surgery in locally advanced rectal cancer.
C. Fernández-Martos, C. Pericay, A. Salud, B. Massutí +6 more
2011Journal of Clinical Oncology13 citations
Semantic Scholar
Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer.
A. Muñoz, C. Pericay, C. García-Girón, V. Alonso +6 more
2014Oncology Research12 citations Open access
Semantic Scholar
Addition of bevacizumab to induction plus concomitant capecitabine-oxaliplatin (XELOX) chemoradiotherapy (CRT) in MRI poor prognosis locally advanced rectal cancer: Avacross study.
M. Nogué, A. Salud, P. Vicente, C. Pericay +6 more
2009Journal of Clinical Oncology12 citations
Semantic Scholar
Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
J. Porcel, A. Salud, M. Vives, A. Esquerda +1 more
2005Clinical Biochemistry12 citations
Semantic Scholar
XELOX (capecitabine and oxaliplatin) as 1st line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC).
L. López-Gómez, P. Escudero, A. Yubero, J. Feliu +6 more
2004Journal of Clinical Oncology12 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Pericay×12
Invite
C. Pericay — researcher profile on SciRah
J. Porcel×12
Invite
J. Porcel — researcher profile on SciRah
V. Alonso×11
Invite
V. Alonso — researcher profile on SciRah
S. Bielsa×11
Invite
S. Bielsa — researcher profile on SciRah

C. Fernández-Martos

×10

Invite

C. Fernández-Martos — researcher profile on SciRah

Invite

P. Escudero — researcher profile on SciRah

Invite

F. Losa — researcher profile on SciRah

Invite

J. Feliu — researcher profile on SciRah

Invite

C. Montagut — researcher profile on SciRah

Invite

A. Esquerda — researcher profile on SciRah

Invite

J. Aparicio — researcher profile on SciRah

Invite

J. Maurel — researcher profile on SciRah